CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Diasome Pharmaceuticals, a clinical stage diabetes therapeutics company, announced today that four abstracts were accepted for publication at the 68th Annual Meeting of the American Diabetes Association, being held June 6 through June 10 at the Moscone Convention Center in San Francisco, Ca.
